A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

NCT05361733 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Focus of the Study: Safety of XFB19

Interventions

DRUG: XFB19
DRUG: Placebo

Sponsor

Xfibra, Inc.

Collaborators

[object Object]
[object Object]